Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from the sovleplenib ESLIM-01 Phase III trial, as well as several investigator-initiated studies of compounds ...

Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...

In a world where medical advancements often steal the spotlight, one act of kindness continues to save lives in profound ways ...

Panic surrounding dengue or chikungunya and many new testing centres having come up in the state capital - diaognosing more people - are termed as the reasons for the spike ...

Rallybio Corporation , a clinical-stage biotechnology company translating scientific advances into transformative therapies ...

Learn more about the similarities and differences between fetal and neonatal alloimmune thrombocytopenia (FNAIT) and HDFN.

Dengue fever is most often transmitted to humans by the Aedes aegypti mosquito. Dengue fever can be caused by any of four related dengue viruses (DENV-1 to DENV-4).Fever is common in several parts of ...

Thrombocytopenia occurs when the number of platelets in your blood drops below a certain level. In gestational ...

As dengue cases soar in Lucknow, platelet demand has surged over two-and-a-half times, prompting urgent calls for voluntary ...

The European Medicines Agency recommended the antihemorrhagic drug eltrombopag to treat forms of thrombocytopenia and ...

Thrombocytopenia (low in platelet count) is the hallmark of the dengue and prophylactic (a medicine or course of action used to prevent disease) platelet transfusion is the one of the treatment to ...